8mm Dual-Sensor Catheter Delivers High-Power Ablations

 

May 9, 2007

The Stereotaxis Navistar RMT Dual Sensor magnetically enabled 8mm ablation catheter has received FDA approval and will soon be commercially available in the U.S. The 8mm catheter expands electrophysiology applications for the Stereotaxis Magnetic Navigation system by providing physicians the ability to deliver high power ablations for the treatment of atrial arrhythmias.

Atrial flutter, a common atrial arrhythmia estimated to represent 25 percent of the over 400,000 ablation procedures performed worldwide each year, is routinely treated with 8mm catheters. Successful European cases have been completed at San Raffaele University Hospital in Milan, Italy and the Hanseatic Heart Center/St. Georg, Hamburg, Germany.

The content of this field is kept private and will not be shown publicly.
Type the characters you see in this picture. (verify using audio)
Type the characters you see in the picture above; if you can't read them, submit the form and a new image will be generated. Not case sensitive.